Ophtaphil SRL
Ophtaphil reported total assets of 798,139 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026).
The score of Ophtaphil shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +39 % Total assets +18 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ophtaphil's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 126,094 € | ||||
| Equity | 675,817 € | ||||
| Cash | 159,232 € | ||||
| EBITDA | 193,975 € | ||||
| Total assets | 798,139 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 13 Jun 2023
- Year ended 31 Dec 2021filed on 12 Aug 2022
Ophtaphil's financial analysis
- Solvency84.7%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ophtaphil
Ophtaphil's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0471.792.558
- VAT number
- BE0471792558
- Peppol
- Registered · 0208:0471792558 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Apr 2000
- Registered office
- 5600 Philippeville
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Ophtaphil (SRL) has been based in Philippeville since 2000, active in: medical specialists activities. For 2025, it reports a net profit of 126,094 € and equity of 675,817 €; its revenue is not published. Its solvency stands at 84.7%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ophtaphil
Companies in the same business, of comparable size and area, outside its group.
- Dokter J. Vermeulen Medical specialists activities Geel · balance sheet 798,114 €
- Dr. Vercauteren Roeland Medical specialists activities Mortsel · balance sheet 798,112 €
- Dareval Medical specialists activities Mons · balance sheet 798,655 €
- Dr. D. Loose, NKO Medical specialists activities Ghent · balance sheet 789,827 €
- Deroux Medical specialists activities Braine-l'Alleud · balance sheet 850,656 €
- Dr. Steven Bessemans Medical specialists activities Bree · balance sheet 797,205 €
- Neurintensive Medical specialists activities Wezembeek-Oppem · balance sheet 799,616 €
- Kadou Alexandre Medical specialists activities Sint-Genesius-Rode · balance sheet 799,958 €
Frequently asked questions about Ophtaphil
What is the revenue of Ophtaphil?
Ophtaphil files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ophtaphil?
In Belgium, the VAT number is the company number prefixed with BE: BE0471792558 for Ophtaphil, if the company is VAT-registered. Its company number (CBE) is 0471.792.558.
Where is the registered office of Ophtaphil?
According to the CBE register, the registered office of Ophtaphil is in 5600 Philippeville.
What is the equity of Ophtaphil?
At the close of the 2025 financial year, the equity of Ophtaphil amounts to 675,817 €, a solvency of 84.7% of total assets.
Who manages Ophtaphil?
The register lists 1 active mandates at Ophtaphil. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ophtaphil
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →